Literature DB >> 2626016

Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.

H Rochefort1, V Cavailles, P Augereau, F Capony, T Maudelonde, I Touitou, M Garcia.   

Abstract

Pro-cathepsin D is overexpressed in breast cancer cells compared to normal mammary epithelial cells. Moreover, its processing and maturation are altered resulting in increased secretion. In estrogen-responsive breast cancer cell lines such as MCF7 cells and ZR75-1 cells, the 2.2-kb cathepsin D mRNA is accumulated specifically by estrogens and growth factors. Estrogen regulation is mostly transcriptional, while growth factors stabilize the mRNA and act indirectly. In estrogen-receptor-negative cell lines, there is a constitutive high production of cathepsin D mRNA. Moreover in uterine cells, progesterone is the inducer rather than estrogen, indicating the complexity of regulation by steroids, depending on the tissue. The increased production of cathepsin D appears to be correlated with the aggressiveness of the tumour, as shown by retrospective clinical studies, suggesting a role in mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2626016     DOI: 10.1016/0022-4731(89)90080-0

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  20 in total

1.  Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women.

Authors:  S Kalla Singh; Q W Tan; C Brito; M De León; D De León
Journal:  Growth Horm IGF Res       Date:  2010-03-27       Impact factor: 2.372

2.  Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells.

Authors:  Sharda Vyas; Yayesh Asmerom; Daisy D De León
Journal:  Growth Factors       Date:  2006-03       Impact factor: 2.511

3.  Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Authors:  Xiao-Feng Huang; Chun-Mei Wang; Xiao-Wen Dai; Zhen- Jiang Li; Bo-Rong Pan; Li-Bin Yu; Bin Qian; Li Fang
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 4.  Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.

Authors:  Elzbieta Skrzydlewska; Mariola Sulkowska; Mariusz Koda; Stanislaw Sulkowski
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

Review 5.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

6.  Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years.

Authors:  W Domagala; G Striker; A Szadowska; A Dukowicz; K Weber; M Osborn
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

7.  Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer.

Authors:  W Remmele; J Sauer-Manthey
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  Evaluation of cathepsin D as a prognostic factor in breast cancer.

Authors:  P M Ravdin
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cells.

Authors:  Jessica L Schwartz-Roberts; Ayesha N Shajahan; Katherine L Cook; Anni Wärri; Mones Abu-Asab; Robert Clarke
Journal:  Mol Cancer Ther       Date:  2013-02-08       Impact factor: 6.261

10.  Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.

Authors:  Sa Do Kang; Sreejata Chatterjee; Samina Alam; Anna C Salzberg; Janice Milici; Sjoerd H van der Burg; Craig Meyers
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.